Delivery Order SPE2DB24D3013-SPE2DB26FFFQD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,611.92 to AmerisourceBergen Drug Corp for the supply of 20 DRAM 1-CLIC amber vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical and medical supply vendor supporting federal healthcare procurement, with performance originating from the company's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.81 to AmerisourceBergen Drug Corp for the delivery of 20 DRAM 1-CLIC amber vials. This firm fixed-price, non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of pharmaceutical packaging materials to support...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.78 to AmerisourceBergen Drug Corp for 16 DRAM 1-Click Amber Vials, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a routine procurement action for medical supply components necessary to support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,651.68 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under a larger contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small transaction under...
- The Defense Logistics Agency awarded a $1,531.49 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of 16 DRAM 1-Click Amber Vials, with ultimate completion scheduled for October 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of 16 DRAM 1-Click Amber Vials with a ceiling value of $1,024.41. This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for ultimate completion by September 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a $25,763.15 delivery order to AmerisourceBergen Drug Corp on October 5, 2025, with completion scheduled for October 6, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded to the pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,081.71 to AmerisourceBergen Drug Corp for 20 DRAM 1-CLIC Amber Vials on September 25, 2025, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,028.31 to AmerisourceBergen Drug Corp on October 3, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,060.31 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFQDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,015.30 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of 16 DRAM 1-CLIC amber vials. This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion by October 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems, with its contract awards demonstrating consistent capability to meet competitive federal requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/17/25 |